Navicon International NAVICON

Pharma Cold Chain Expansion Fuels Demand for Ground Refrigerated Fleets

Pharma Cold Chain Expansion Fuels Demand for Ground Refrigerated Fleets

As global pharma airfreight networks expand, Europe's ground-based refrigerated transport and cold chain logistics providers face rising demand for GDP-compliant insulated vans and temperature controlled shipping solutions.

DHL Group's recent announcement of a EUR 2 billion investment in its Health Logistics division, including an expanded dedicated Airfreight Cold Chain Network connecting hubs like Brussels and Cincinnati, marks a pivotal shift in how temperature-sensitive medicines, vaccines and cell & gene therapies move around the world. For European cold chain logistics providers, this global airfreight expansion carries a direct and often overlooked implication: every shipment that lands at a major hub still needs a reliable, compliant ground network to reach its final destination.

Industry estimates suggest that around 80% of pharmaceutical products transported within the EU require temperature control, and Europe's cold chain sector is now valued at more than €100 billion annually. As airfreight capacity for pharma grows, so does the volume of temperature-sensitive cargo requiring precise, GDP-compliant handling from airport tarmac to hospital, pharmacy or distribution center — a gap that ground-based refrigerated transport must fill.

The Missing Link: Ground-Based Cold Chain Infrastructure

While long-haul airfreight networks solve the international movement of pharmaceuticals, the critical first- and last-mile legs depend entirely on refrigerated transport equipped to maintain unbroken temperature control. Insulated vans and refrigerated semi-trailers must be capable of multi-temperature configurations, rapid loading, and continuous monitoring to satisfy Good Distribution Practice (GDP) requirements for medicines arriving at hubs such as Brussels, Frankfurt or Amsterdam.

Navicon's fleet of refrigerated vehicles, insulated vans and semi-trailers is engineered precisely for this purpose, bridging the gap between international airfreight cold chain networks and the pharmacies, clinics and hospitals that depend on timely, temperature-accurate delivery across Europe's road network.

Cross-Docking and Border Complexity Add New Pressure

Brexit-related customs checks continue to drive demand for cross-docking hubs at ports including Calais and Rotterdam, adding new layers of complexity to maintaining an unbroken cold chain across borders. Combined with the broader industry shift toward digital fleet monitoring — seen in moves like Schmitz Cargobull's acquisition of telematics firm AGS — continuous temperature data across every handoff point, from air to road to cross-dock, has become essential for both regulatory compliance and product integrity.

Positioning for Growth in Pharmaceutical Cold Chain Logistics

As global investment in pharmaceutical airfreight accelerates, European carriers and distributors need dependable, compliant ground partners more than ever. Navicon continues to expand its insulated van and refrigerated semi-trailer offerings with telematics-enabled temperature logging, ensuring seamless, verifiable cold chain continuity from airport hub to final delivery — supporting Europe's rapidly growing pharmaceutical cold chain logistics network.

Need Refrigerated Transport Solutions?

Contact Navicon International to discuss your cold chain logistics requirements across Europe.

Request a Quote